Neural stem cells (NSCs) possess therapeutic potentials to reverse complex pathological processes following spinal cord injury (SCI), but many obstacles remain that could not be fully overcome by NSC transplantation alone. Combining complementary strategies might be required to advance NSC-based treatments to the clinical stage. The present study was undertaken to examine whether combination of NSCs, polymer scaffolds, neurotrophin-3 (NT3), and chondroitinase, which cleaves chondroitin sulfate proteoglycans at the interface between spinal cord and implanted scaffold, could provide additive therapeutic benefits. In a rat hemisection model, poly( -caprolactone) (PCL) was used as a bridging scaffold and as a vehicle for NSC delivery. The PCL scaffolds seeded with F3 NSCs or NT3 overexpressing F3 cells (F3.NT3) were implanted into hemisected cavities. F3.NT3 showed better survival and migration, and more frequently differentiated into neurons and oligodendrocytes than F3 cells. Animals with PCL scaffold containing F3.NT3 cells showed the best locomotor recovery, and motor evoked potentials (MEPs) following transcranial magnetic stimulation were recorded only in PCL-F3.NT3 group in contralateral, but not ipsilateral, hindlimbs. Implantation of PCL scaffold with F3.NT3 cells increased NT3 levels, promoted neuroplasticity, and enhanced remyelination of contralateral white matter. Combining chondroitinase treatment after PCL-F3.NT3 implantation further enhanced cell migration and promoted axonal remodeling, and this was accompanied by augmented locomotor recovery and restoration of MEPs in ipsilateral hindlimbs. We demonstrate that combining multifaceted strategies can maximize the therapeutic benefits of NSC transplantation for SCI. Our results may have important clinical implications for the design of future NSC-based strategies.
INTRODUCTION
tional outcomes after SCI, warranting the development of a multifaceted combinatorial approach to achieve clinically relevant functional recovery (19, 50) . Spinal cord injury (SCI) interrupts neural connections between the brain and the rest of the body, leading to a Preclinical studies of various animal models of SCI have shown that neural stem or progenitor cells (NSCs) paralysis and loss of sensation below the level of injury. The pathological consequences of SCI are multitude:
possess multiple therapeutic potentials that might be exploited to reverse diverse pathological processes. For exdeath of local segmental neurons and glial cells, severance of axons in white matter, formation of fluid-filled ample, NSCs can modify the injured microenvironment and provide neuroprotection (27, 41) . Grafted NSCs can cystic cavities, and demyelination of spared white matter (6,33,52). All these pathological processes, at least to replace lost neuronal populations at segmental levels (15, 60) , and NSCs or lineage restricted glial progenitor some degree, contribute together to the devastating func-cells can differentiate into myelinating oligodendrocytes MATERIALS AND METHODS and augment the remyelination of spared tissues (10,15, Establishment of Human NSCs Modified 30, 31, 46) . Furthermore, NSC transplantation has been to Secrete NT3 reported to increase axonal regeneration and/or plasticity Telencephalon tissues from gestational week 15 hu-(40,44). For these reasons, it is anticipated that the NSC man fetal brains were utilized to generate an immortaltransplantation will become a viable and effective theraized human NSC line (F3) using a retroviral vector enpeutic option to improve functional outcome after SCI coding v-myc, as described previously (18,34). The (16,38).
permission to use fetal tissues was granted by the CliniHowever, many considerable obstacles remain to be cal Research Screening Committee involving Human overcome before NSC transplantation becomes available Subjects of the University of British Columbia. The in clinic. The formation of fluid-filled cystic cavities se-PG13 mouse packaging cell line was transfected with verely impedes axonal growth in lesion areas, and it has plasmid pLHCX-NT3 vector containing full-length hubeen suggested that transplanted NSCs are not capable man NT3 cDNA (ATCC, Manassas, VA) using lipofecof bridging these cavitary lesions (51, 59) . Furthermore, tamine. Retroviral supernatants obtained from the packsurvival and migration of grafted NSCs are often limited aging cells were applied to F3 NSCs. Hygromycinin the injured spinal cord (26, 37, 48) , and NSCs transresistant clones were screened and isolated, and one of planted into injured spinal cord tissue frequently either the clones (F3.NT3) was expanded and used for the remain undifferentiated or differentiate predominantly transplantation. into astrocytes, which can contribute to glial scar formation (11,12). In addition, glial scars and inhibitory extra-
Pretreatment of PCL Scaffolds and the Cell cellular matrices such as chondroitin sulfate proteogly-
Seeding Procedure cans (CSPGs) could interfere with migration and axonal A biocompatible poly( -caprolactone) (PCL) scaffold growth of grafted NSCs, reducing the possibility of the was used in this study. The scaffold was produced by proper integration of NSCs with the host neural circuit reacting PCL diols (MW = 2,000) with acryloyl chloride (26, 32, 35) .
and fabricated using a gas-foaming/salt-leaching method Therefore, we reasoned that a combination of comple- (36) . The dimensions of PCL scaffold were determined mentary strategies aimed at removing specific obstacles to fit hemisected lesion cavities. Before cell seeding, the would potentiate the efficacy of NSC-based treatments.
PCL scaffolds were sterilized with 70% ethanol, and Previous studies have shown that NSC transplantation in then washed five times in distilled water, after which combination with a complementary strategy provided they were subjected to vacuum desiccation for 10 min improved therapeutic benefits as compared with NSC to remove trapped air bubbles. Before seeding, F3 or alone. Teng et al. found that implanting polymer scaf-F3.NT3 cells were grown attached to culture dishes, disfold seeded with NSCs led to an improved functional sociated into single cells by a brief trypsin treatment, recovery (57). Brain-derived neurotrophic factor (BDNF) and then suspended at a density of 10 5 cells/µl. A 2.5-or neurotrophin-3 (NT3) coadministered with NSCs or µl aliquot of medium containing cells was then slowly directly transduced to NSCs improved the survival and injected using a pipette tip into both sides of each scafmigration of grafted NSCs (7, 20, 29, 49, 62) . Moreover, fold (a total of 5 × 10 5 cells/scaffold). The PCL scaffolds combining chondroitinase with NSC grafts to degrade seeded with cells were transferred into a 12-well plate inhibitory extracellular matrices enhanced NSC migraand incubated on shaker at 37°C for at least 3 days betion (26) . What remains to be determined is whether a fore implantation. combination of multifaceted complementary strategies could provide therapeutic benefits of greater magnitude Surgical Procedures and to what extent a multifaceted combinatorial approach could enhance the therapeutic effects of NSC All animal procedures were approved by the Animal Experiment Review Committee at Ajou University transplantation.
In an effort to identify an effective NSC-based treatSchool of Medicine. Adult female Sprague-Dawley rats (250-300 g) were used. After being anesthetized with ment strategy for SCI, we tested whether a combinatorial strategy based on the use of polymer scaffold, NSCs, and 4% chloral hydrate (400 mg/kg), rats were subjected to dorsal laminectomy at the seventh thoracic vertebral NT3 could improve recovery of locomotor function, and whether the inclusion of a chondroitinase treatment to delevel (T7-8). After dura was opened, a chunk of right side spinal cord was excised using iridectomy scissors. grade CSPGs deposited at the interface between the spinal cord and implanted scaffold could augment the therapeuRemaining tissue was removed by vacuum suction until the vertebral body at the ventral side was visualized. tic benefits conferred by this combinatorial strategy.
Special care was taken to confirm that the right side apolis, MN). The detailed procedure was described in an instruction manual provided by the manufacturer. The hemicord was entirely removed and that the lesion did not extend into the left side spinal cord. A PCL scaffold experiment was replicated three times. NT3 levels in the spinal cord tissue implanted with PCL scaffolds seeded seeded with human NSCs was implanted into the lesion site immediately after hemisection. Animals were ranwith F3.NT3 cells were also measured by ELISA. Briefly, 16 animals were sacrificed with an overdose anesthesia domly allocated to four experimental groups: 1) animals that received hemisection alone [control (CTL) group, at 2 weeks post-SCI (N = 4 per group). Spinal cord tissue spanning ±5 mm from the epicenter was dissected N = 8), 2) animals implanted with PCL scaffold without cells (PCL group, N = 7), 3) animals implanted with and homogenized in lysis buffer (4 µl/mg tissue) containing protease inhibitor cocktail (Sigma). To measure PCL scaffold seeded with F3 NSCs (PCL-F3 group, N = 9), and 4) animals implanted with PCL scaffold with NT3 levels only in the host spinal cord tissue, PCL scaffolds were manually detached from the spinal cord tis-F3.NT3 cells (PCL-F3.NT3 group, N = 9). The above animals were sacrificed at 9 weeks after all behavioral sues and not included in the protein extraction. For Western blot analysis, spinal cord tissue blocks (spanand electrophysiological tests had been completed. A different set of animals was sacrificed at 2 weeks postning 2-3 mm) immediately caudal to the tissues used for ELISA were homogenized in the same lysis buffer. SCI for ELISA and Western blot. All animals received daily intraperitoneal cyclosporine (Sandimmun; Novar-
The blots were probed with growth associated protein 43 (GAP-43; 1:3000; rabbit; Chemicon; Temecula, CA) tis, Bern, Switzerland) at a dosage of 10 mg/kg, beginning from 1 day before surgery until sacrifice. Prophyand synaptotagmin (1:3000; mouse; Chemicon) antibodies. All blots were also probed with mouse anti-β-actin lactic antibiotics were injected intraperitoneally on the next day following each surgery. Bladder care was proto control for differences in loading amount. After incubation with peroxidase-conjugated appropriate secondvided until spontaneous voiding resumed.
ary antibodies, antigen-antibody reactions were visualInfusion of Chondroitinase ABC ized using a chemiluminescence kit. Protease-free chondroitinase ABC (C-ase) was purAssessment of Locomotor Recovery chased from the Seikagaku Corporation (Tokyo, Japan). One day prior to infusion, an enzyme aliquot (10 U/ml, Locomotor recovery was assessed using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale 0.2 ml) was loaded into the reservoir of the Alzet 2004 osmotic pump (Durect, Cupertino, CA) and incubated and the grid walk test. Animals were assigned with new identification codes after surgery to ensure that behavovernight at 37°C. Immediately after implantation of PCL scaffold seeded with F3.NT3 cells, a PE-10 tubing ioral performances were rated in a blind manner. The BBB locomotor rating scale was used to measure the (Intramedic, NJ) attached to the osmotic pump was inserted into the subarachnoid space from the intervertequality of hindlimb function during open field locomotion. Because animals were subjected to hemisection inbral space one level rostral to the lesion and slowly advanced under the lamina until the tube opening was jury, right (ipsilateral) and left (contralateral) hindlimbs were assessed separately. For the grid walk test, animals located on top of the implantation site. The osmotic minipumps delivered the enzyme solution at a rate of 0. 25 were pretrained for 7 days before surgery to walk on grid runway (30 × 140 cm with 50 × 50-mm holes) for µl/h continuously for 28 days. The weight equivalent of penicillinase (P-ase; Sigma, St. Louis, MO) was deliva water reward. The test was conducted at 4 and 7 weeks post-SCI, and animals were retrained for 5 days before ered as a control injection. Eighteen animals that received PCL implants seeded with F3.NT3 cells were testing. On the day of tests, four runs were recorded using a three-charge-coupled device (CCD) digital video randomly divided into C-ase (N = 9) and P-ase (N = 9) groups. All these animals were sacrificed at 9 weeks camera, and later analyzed frame by frame in slow motion. The average number of limb placement errors per post-SCI after behavioral and electrophysiological assessments had been done. A different set of animals was run was determined for each animal. sacrificed at 2 weeks post-SCI (N = 3 per group), and Electrophysiological Assessment the spinal cord sections of these animals were subjected to immunohistochemistry with CS56 and C4S antibody
The integrity of the motor pathway through the spinal cord was assessed by the transcranial magnetic motor to detect intact and degraded CSPGs, respectively. evoked potentials (39 To measure the extent of neurofilament (NF)-positive axon growth within PCL scaffolds, two consecutive lonheparinized saline (0.9%), followed by 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4. Spinal gitudinal spinal cord sections that contain the largest lesion areas were chosen. Three regions of interest (ROIs) cords were then dissected, postfixed in 4% paraformaldehyde at room temperature for 2 h, and then cryopromeasuring 1422 × 1249 µm were placed inside PCL scaffolds along the rostral, caudal, and medial borders tected in a graded series of sucrose solutions. Longitudinal or transverse 20-µm sections were cut using a cryostat in each section. NF-positive axons within these ROIs were manually traced at 200× magnifications using the (Leica) in a 1:10 series and thaw-mounted onto Super Frost plus slides. For immunohistochemistry, spinal cord Metamorph software 7.01 (Universal Imaging Corporation, Downingtown, PA). Numbers and lengths of axons sections were incubated overnight at 4°C with antihuman mitochondria (1:300; mouse and rabbit; Chemiin three ROIs were calculated using Metamorph software and averaged for the two sections in each animal. were imaged at 200×. ROIs were then drawn using a freehand selection tool to cover the entire ventral horn. 200; mouse; Sigma), anti-C4S (degraded CSPGs; 1:200; mouse; Chemicon), and rabbit 5-HT antibodies (5- The numbers of pixels occupied by the serotonergic (5-HT) fibers at the ventral horns were quantified. Serotonhydroxytryptamine; 1:5000; Immunostar, Hudson, WI). Spinal cord sections were then washed and incubated ergic fiber densities of right side were normalized versus those of left side and percentage serotonergic innervwith fluorophore-tagged appropriate secondary antibodies. For fluorescence staining, cover slips were mounted ations of lesioned versus nonlesioned sides were calculated and averaged for the three sections per animal. onto glass slides using Gelvatol and examined under an Olympus confocal laser scanning microscope.
Extent of Myelination in White Matter Quantitative Measurements of Cell Numbers
Tissue sections were immersed for 8 min in a staining and Axonal Growth solution consisting of 240 ml of 0.2% eriochrome cyanine RC (Sigma) and 10 ml of 10% FeCl 3 ؒ6H 2 O (Sigma) Human mitochondria-positive cells in the entire longitudinal spinal cord sections were counted using unbiin 3% HCl. Sections were then washed with running tap water followed by differentiation in 1% aqueous ased stereology. Cell counting was performed on an Olympus BX51 Microscope that was coupled with the NH 4 OH. In each animal, the eriochrome-stained spinal cord section containing the largest lesion area was choStereo Investigator 8 software (MBF Bioscience, Williston, VT). Human mitochondria-positive cells within opsen, and the two more sections 200 µm dorsal and ventral each to the chosen section were included in the analtical dissectors randomly placed in regions of interest were counted using stereological criteria. Stereological ysis (three consecutive sections per animal). Stained sections were viewed on an optical microscope (Olymestimation was performed systematically using the formula embedded in the software. To determine the perpus BX51) and images were captured using a CCD camera (JVC digital camera KY-F1030). A single ROI centage of grafted human NSCs that were colocalized (120 × 90 µm) per section was chosen in contralateral dia were measured. As expected, freely grown F3.NT3 (dissociate culture) secreted almost 10-fold more NT3 white matter. The areas of myelin staining above a predetermined threshold were quantified using Image J into culture media than parental F3 cells. Although NT3 levels were reduced by almost a half, F3.NT3 cells software (National Institutes Health). Percentages of ROIs stained by myelin were averaged for three sections seeded into PCL scaffolds still secreted substantial amounts of NT3 (Fig. 1B) . per animal.
Right-sided spinal cord hemisection was performed Statistical Methods at the T7 level and PCL scaffolds with or without seeded human NSCs were implanted immediately into hemisecStatistical analysis was performed using SPSS version 12.0 (Chicago, IL) or GraphPad Prism software ted cavities to bridge lesion sites. At 9 weeks post-SCI, PCL scaffolds were found to adhere well to residual spiversion 4.0 (San Diego, CA). The unpaired Student's ttest or one-way ANOVA followed by Tukey's post hoc nal cord tissues and to form a rostrocaudal bridge across lesion cavities ( Fig. 2A, B (Fig. 2G) . The total number of human NSCs in the entire rostrocaudal extent was also significantly higher for PCL scaffolds and cultured for at least 3 days before implantation. Scanning EM showed that seeded NSCs F3.NT3 than F3 cells (29,256 ± 9,291 and 14,507 ± 3,696, respectively; p < 0.001), indicating that the overall were attached to the inner walls of the PCL scaffold and packed into its micropores (Fig. 1A) . To determine survival was better in F3.NT3 cells. We also found that the mean migration distance was significantly greater in whether seeded F3.NT3 cells survive and function properly inside PCL scaffolds, levels of NT3 in culture meanimals with PCL-F3.NT3 grafts (p < 0.01) (Fig. 2H) . F3 or F3.NT3 cells that migrated into remaining spithan F3 cells (Fig. 3B , E, G). Approximately 10% of F3 and F3.NT3 cells that migrated into remaining spinal nal cord tissues appeared to acquire mature neural cell phenotypes (Fig. 3) . F3.NT3 cells observed in remaining cord were found to be positive for GFAP, and there was no difference between the two cells (Fig. 3C, F, G) . spinal cord tissue were frequently colocalized with neuronal marker MAP-2 (Fig. 3D, G) . On the other hand, However, in contrast to F3 and F3.NT3 cells observed in remaining spinal cord tissues, human NSCs that reonly a small proportion of F3 cells differentiated into MAP-2-positive neurons (Fig. 3A, G) . F3.NT3 cells also mained within the scaffolds showed no evidence of differentiation into mature neural cells. more frequently differentiated into oligodendrocytes score at this time point was significantly less than that in Assessment of Functional Recovery PCL-F3.NT3 group (15.1 ± 1.5 for ipsilateral and 16.6 ± 1.3 for contralateral). At 7 weeks post-SCI, animals in BBB locomotor and grid walk tests were performed to assess locomotor recovery. All groups showed similar PCL-F3.NT3 group fully regained coordinated plantar stepping with improved ankle positioning. Implantation BBB scores immediately after injury (Fig. 4A, B) . Locomotor deficits rapidly recovered during the first two of PCL scaffold alone provided slight functional benefits compared to the injury alone (CTL) group. Repeated weeks in all animals. Animals in PCL-F3.NT3 group exhibited clearly better locomotor recovery than those measures two-way ANOVA revealed a highly significant treatment effect over time in both hindlimbs (p < in the other groups at 3 weeks and continued to show better improvement until 7 weeks post-SCI. Locomotor 0.001 for both hindlimbs). Tukey's post hoc analysis showed significant differences between PCL-F3.NT3 scores also improved in PCL-F3 group (mean BBB score at 7 weeks post-SCI, 12.7 ± 1.7 and 13.9 ± 1.8 for and the other three groups (Fig. 4A, B) . The difference between PCL-F3 and CTL groups was also statistically ipsi-and contralateral, respectively), but the mean BBB Recovery of Basso, Beattie, and Bresnahan (BBB) locomotor scores over the 7-week period after injury for ipsilateral (right) (A) and contralateral (left) (B) hindlimbs. Animals in PCL-F3.NT3 group showed best recovery. *p < 0.05, **p < 0.01, and ***p < 0.001 by repeated measures two-way ANOVA followed by Tukey's post hoc analysis. (C, D) Grid walk. Average numbers of ipsilateral (C) and contralateral (D) hindlimbs placement errors on grid per run were counted at 4 and 7 weeks post-SCI. Animals in PCL-F3.NT3 group showed highest accuracy on grid walk. *p < 0.05, **p < 0.01, and ***p < 0.001 by one-way ANOVA followed by Tukey's post hoc analysis. N = 8, 7, 9, and 9 for control (CTL), PCL, PCL-F3, and PCL-F3.NT3 groups, respectively, for all graphs. Error bars represent mean ± SEM.
significant. In grid walk, animals in CTL group made further reduced in PCL-F3 group. Animals in PCL-F3.NT3 groups showed the highest accuracy in hindsignificantly more frequent errors in both hindlimbs than those in the other groups (Fig. 4C, D) . Implantation of limb placement. One-way ANOVA followed by Tukey's post hoc analysis revealed a statistically signifi-PCL scaffold alone markedly reduced the number of errors (p < 0.001 compared to CTL). These errors were cant difference between PCL-F3.NT3 and PCL-F3 groups. Taken together, these results suggest that PCLtively) (Fig. 5A, B) . MEP responses were almost absent in CTL group in both hindlimbs. None of PCL, PCL-F3.NT3 implantation provided the greatest behavioral benefits.
F3, and PCL-F3.NT3 groups showed ipsilateral MEP response with the amplitude of more than 1 mV (Fig. 5A , We further examined whether the improvements in hindlimb locomotor function were accompanied by elec-C). In the contralateral side, none of PCL alone group and only two of PCL-F3 group (22%, 2/9) exhibited aptrophysiological restoration of motor evoked potentials (MEPs). In sham-operated animals, transcranial magpreciable MEP response (>1 mV). In PCL-F3.NT3 group, 67% (6/9) animals showed MEP responses with netic stimulation of the vertex readily elicited MEP responses at both hindlimbs of mean amplitudes 7.2 ± 1.6 the amplitude of more than 1 mV (Fig. 5B) . Mean amplitude of PCL-F3.NT3 groups in the contralateral side and 7.3 ± 1.2 mV (ipsilateral and contralateral, respec- was 2.6 ± 1.7 mV and significantly higher than those of was also compromised after right side spinal cord hemisection (Fig. 5) . This was consistent with the finding of the other groups (p < 0.001) (Fig. 5D) . a recent study in which a decline in electrical transmisMechanism of Functional Recovery Mediated sion through contralateral uninjured fibers was sugby PCL-F3.NT3 Implantation gested to be due to chronic progressive demyelination (1). Because NT3 has been known as a strong signal First, we determined whether implantation of PCL scaffolds with F3.NT3 increased the concentration of to promote myelination (43,53), we reasoned that the recovery of contralateral MEP responses in PCL-F3. NT3 in host spinal cord tissue at 2 weeks after injury (Fig. 6A) . ELISA showed that levels of NT3 in the spi-NT3 group was due, at least in part, to improved myelination in contralateral white matter. Eriochrome cyanine nal cord of PCL-F3.NT3 group were significantly higher than in the other three groups (p < 0.05 vs. PCL-F3, and (EC) staining of myelin in contralateral white matter of CTL group showed a coarse arrangement of myelinating p < 0.01 vs. PCL and CTL groups). We also examined whether PCL-F3.NT3 implantation promoted neuroplasfibers with frequent unstained foci interspersed with myelin fragments (Fig. 6I) , and the staining pattern was ticity in the spinal cord caudal to lesions where the spinal locomotor center is located at the 2 weeks after insimilar with PCL and PCL-F3 groups (Fig. 6J, K) . In contrast, myelinating fibers were more compactly arjury when rapid behavioral improvement was observed. GAP-43 and synaptotagmin were chosen as a marker for ranged in PCL-F3.NT3 group without apparent demyelinating foci (Fig. 6L ). Quantification revealed signifiaxonal plasticity and synaptogenesis, respectively. Western blot showed that PCL-F3.NT3 implantation markcant increases of EC-stained areas in PCL-F3.NT3 group compared to the other groups (p < 0.001) (Fig. 6M) . edly increased the expression of GAP-43 and synaptotagmin at 2 weeks post-SCI (Fig. 6B) . In fact, GAP-43
Degradation of CSPGs Enhanced Migration levels in PCL-F3.NT3 group were almost fourfold of Transplanted Cells and Axonal Remodeling higher and synaptotagmin levels were threefold higher than in CTL group (Fig. 6C, D) . GAP-43 expression was It has been shown that CSPGs deposition around the injury sites inhibits axonal regeneration and/or cellular also significantly increased in PCL-F3 group compared to CTL and PCL groups (Fig. 6B, D) , but levels of migration (17, 26, 45) . Therefore, we asked if the combined use of CSPG degrading enzyme could provide ad-GAP-43 expression in PCL-F3.NT3 group was significantly higher than in PCL-F3 group (p < 0.01). Consisditional therapeutic benefits in animals with implantation of PCL scaffold with F3.NT3 cells. Chondroitinase tent with the Western blot data, GAP-43 immunoreactivity in neuropil was found to increase in the caudal gray ABC (C-ase) or a control penicillinase (P-ase) was infused using osmotic minipumps in animals with PCLmatter (lumbar level), especially in the intermediate regions and ventral horns, of animals in PCL-F3.NT3 F3.NT3 implantation. C-ase infusion almost completely abolished CS56 staining (intact CSPGs), which was group (Fig. 6G, H) . In contrast, only subtle immunoreactivity was observed in CTL group (Fig. 6E, F) .
densely observed around PCL scaffolds in P-ase control animals (Fig. 7) . C-ase treatment also revealed immunoElectrophysiological assessment showed that electrical transmission through contralateral (left) spinal cord reactivity against C4S (degraded CSPGs), indicating that C-ase successfully degraded CSPGs at the interface beimportant role in locomotor recovery after SCI (8). Although serotonergic (5-HT) axon areas in the contralattween PCL scaffolds and spinal cord tissue. Degradation of CSPGs promoted the migration of F3.NT3 cells into eral ventral horn tended to be higher in C-ase group, the difference was not statistically significant (6.1 ± 4.9% residual spinal cord tissue (Fig. 8A, B) . In P-ase group, F3.NT3 cells migrated across the interface between scafand 9.6 ± 6.0%. in P-ase and C-ase groups, respectively; p = 0.19). In P-ase group, mean serotonergic axon denfolds and spinal cord, but a large proportion of migrating cells did not cross the GFAP-positive glial scars or resity in the ipsilateral ventral horn was only 32.8 ± 8.8% of contralateral side (Fig. 9K ). C-ase treatment substanmained adjacent to glial scar fronts (Fig. 8C, D) . Combination of C-ase increased the extent of F3.NT3 cells that tially increased the extent of serotonergic innervation in the ipsilateral side, reaching 56.2 ± 11.5% of the contracrossed glial scar fronts, especially in the caudal direction (Fig. 8E, F) . The total number of cells was not siglateral side (Fig. 9H, K) . nificantly different between C-ase and P-ase groups Degradation of CSPGs Augmented the Functional (34,228 ± 17,706 and 25,695 ± 4,226, respectively; p = Recovery Mediated by PCL-F3.NT3 Implantation 0.18). However, numbers of F3.NT3 cells that migrated into rostrocaudal spinal cord were significantly higher at BBB locomotor test was performed to examine whether C-ase treatment further improved the quality of several sites in C-ase group (Fig. 8G) , and the longest migration distance from the implant was also signifihindlimb locomotion in animals implanted with PCL-F3.NT3. Animals treated with C-ase (N = 9) showed becantly greater in C-ase group (p < 0.01). The extent of differentiation of F3.NT3 cells into mature neural cell havioral recovery superior to P-ase group (N = 9) in both hindlimbs (Fig. 10A, B) . Repeated measures twophenotypes was not different between P-ase and C-ase groups (data not shown).
way ANOVA revealed a significant treatment effect over time (p < 0.05 for both hindlimbs). Locomotor perThe extent of axonal growth into PCL scaffolds (Fig.  9A-D) was also evaluated. In P-ase group, only a small formance was also evaluated at 4 and 7 weeks post-SCI using the grid walk test. C-ase treatment significantly number of short neurofilament-positive axons were observed inside PCL scaffolds, and these were was mostly improved the accuracy of hindlimb placement compared to P-ase treatment in both hindlimbs (Fig. 10C, D) . limited to the very vicinity of the interface (Fig. 9A, B) . In contrast, the number of axons observed inside PCL MEP responses to transcranial magnetic stimulation were measured to compare electrophysiological recovscaffolds was markedly higher in C-ase group (Fig. 9C,  D, I ), and the lengths of ingrowing axons were also ery (Fig. 10E, F) . C-ase treatment in animals implanted with PCL-F3.NT3 recovered recognizable MEP responses greater in C-ase group (Fig. 9J) . We also compared the extent of lumbar ventral horn innervation by serotonerin ipsilateral hindlimbs, where no significant MEP recovery was observed by PCL-F3.NT3 implantation (Fig.  gic fibers (Fig. 9E-H) , which are thought to play an 5A, C). Only 11% (1/9) of animals in P-ase group exhibCSPGs augmented the behavioral and electrophysiological recovery mediated by PCL-F3.NT3 implantation. ited ipsilateral MEP response with the amplitude of more than 1 mV, whereas this percentage was elevated DISCUSSION in C-ase group (67%, 6/9). The mean amplitude was also significantly different in C-ase group (1.4 ± 0.7 mV
The present study demonstrated that the implantation of polymer scaffold seeded with NT3 overexpressing in C-ase and 0.6 ± 0.5 mV in P-ase group, p < 0.05) (Fig. 10E) . However, MEP amplitude was not signifiNSCs provided marked behavioral and electrophysiological recovery in a rat hemisection SCI model. Degracantly changed in contralateral hindlimbs (Fig. 10F) , where implantation of PCL scaffolds with F3.NT3 aldation of CSPGs deposited at the interface between scaffolds and spinal cord tissue further enhanced the ready significantly recovered MEP responses (Fig. 5B,  D) . Collectively, these data indicated that degradation of therapeutic benefits of PCL-F3.NT3 implantation. The full combination enabled the injured rats to attain wellneurotrophic factor gene, and 3) modulation of inhibitory extracellular matrix. The combination of all these coordinated plantar stepping accompanied by improved ankle positioning and toe clearance (mean BBB score, strategies together was feasible and led to greatest functional recovery, providing an applicable and promising 16.0 ± 1.5 and 17.4 ± 1.3 for ipsi-and contralateral hindlimbs, respectively) and reduced paw placement erframework for future NSC-based transplantation therapies targeting spinal cord repair. rors on grid to a minimum (3.5 ± 1.0 and 2.1 ± 1.0 per run for ipsi-and contralateral hindlimbs, respectively).
The implantation of artificial scaffolds has been employed to bridge lesion cavities and to create a favorable Furthermore, animals with the full complement of combinatorial strategies regained bilateral MEP responses to tissue environment for axonal growth (9,21). Various scaffolding materials including biodegradable polymers transcranial magnetic stimulation. Therefore, our study highlights the additive benefits conferred by combining have been tested in animal models of SCI (24, 47, 54) . In the present study, we found that the polymer scaffold the following complementary strategies: 1) transplantation of NSCs with polymer scaffold, 2) incorporation of itself could provide some therapeutic benefits in terms of behavioral recovery. Animals with PCL scaffold mer scaffolds may deter the infiltration of inflammatory cells and fibroblasts into the lesion cavities with supalone exhibited significantly higher precision in hindlimb placement during the grid walk than those with inpression of glial scar formation (57). In addition to their own positive contribution, bioengineered polymer scafjury alone. A previous study also reported a significant functional improvement by implantation of polymer folds may find their versatile utility in integrating combinatorial strategies, especially cell-based interventions scaffold (57). Implantation of polymer scaffolds may provide mechanical support and prevent instability-related (47,61). As also shown in the present study, polymer scaffolds have proved to be compatible with a variety of functional impairments. Furthermore, implanted poly- cell types and successfully delivered cells of therapeutic neurons receive supraspinal inputs). This suggests that neuroplasticity was enhanced in a regionally specific interests to the lesioned spinal cord (23, 47, 54, 56) . The PCL scaffold in our study appeared to function like a manner and that synaptic connections were actively remodeled only in motor pathway, but not in behaviorally reservoir supplying migratory NSCs to the host spinal cord. Polymer scaffolds are primarily expected to funcirrelevant regions. It is also possible that F3.NT3-derived neurons migrating to host spinal cord contribtion as a bridge filling tissue defects (9). Although the PCL scaffolds physically filled the lesion cavity by prouted to the observed locomotor recovery by participating in the formation of new intraspinal relay circuits (2). viding structural support, they were not able to guide axonal growth without the addition of C-ase infusion. It NT3 can directly enhance oligodendrocyte precursor proliferation and survival (3, 4) and also promotes myhas been suggested that glial scars forming on-and offramps of polymer scaffolds can impede their bridging elination by endogenous oligodendrocytes (43) . In this regard, it was intriguing to find that MEP response was function by preventing axonal growth in and out of polymer scaffolds (21).
not elicited in the contralateral hindlimbs after hemisection injury. A recent study demonstrated that electrical Parental NSCs (F3 cells) grafted with PCL scaffolds survived the transplantation and migrated to host spinal transmission through contralateral spared white matter was impaired, and this was ascribed to a decrease in cord. Although implantation of PCL scaffold seeded with F3 cells appeared to improve accuracy of hindlimb the number of myelinated axons (1) . Our data strongly suggested that the absence of MEP response in conplacement compared to PCL alone group, behavioral recovery assessed by BBB score was not significantly diftralateral hindlimb (Fig. 5B, D) was due to the demyelination of contralateral white matter and that MEP referent between PCL-alone and PCL-F3 groups. The incorporation of NT3 gene into F3 cells substantially covery could be explained by greater myelination in PCL-F3.NT3 group. improved cell survival and migration. F3.NT3 cells were more numerous than F3 cells along the rostrocaudal exAlthough PCL-F3.NT3 implantation resulted in substantial recovery of locomotor function, we hypothetent from the implantation site. Furthermore, the maximal distance of F3.NT3 migration was also markedly sized that CSPGs surrounding PCL scaffolds would still limit the extent of functional benefits. The present study greater than that of F3 cells. A previous study reported that NT3 treatment, by acting through its cognate recepshowed that degradation of CSPGs by intrathecal infusion of C-ase enhanced migration of F3.NT3 cells to the tor TrkC, enhanced the survival and migration of transplanted NSCs in the rat spinal cord (13). In addition, spinal cord and increased the extent of axonal growth into PCL scaffolds. This enhancement in migration inwe found that F3.NT3 cells differentiated into mature neurons and oligodendrocytes more frequently than F3 duced by C-ase could increase the number of F3.NT3-derived neurons or oligodendrocytes located in host cells. Therefore, the incorporation of NT3 gene could positively regulate the intrinsic properties of grafted spinal cord, allowing more chances for intraspinal relay circuit formation or replacing lost oligodendrocytes. BeNSCs such as survival, migration, and differentiation in an autocrine or paracrine fashion. As a result, a much cause surrounding CSPGs inhibit axonal growth into scaffolds, PCL scaffolds would not function adequately larger number of new neurons and oligodendrocytes derived from NSCs were supplied to the host spinal cord as an actual bridge without C-ase (21). Therefore, degradation of CSPGs may be essentially required for the by PCL-F3.NT3 implantation.
The animals implanted with PCL-F3.NT3 exhibited proper bridging functions either by polymer scaffold or other biological grafts (14, 32) . The increases in ipsilatbetter locomotor recovery than those in the other three study groups. We speculate that several mechanisms eral 5-HT innervation may explain our observation that MEP responses were significantly recovered by C-ase may be responsible for PCL-F3.NT3-mediated functional recovery. Increased NT3 concentration in host in ipsilateral hindlimbs (Fig. 10E) , where PCL-F3.NT3 implantation failed to restore recognizable MEP respinal cord tissue (Fig. 6A) could promote neuroplasticity in the caudal spinal cord, which is directly responsisponses (Fig. 5A, C) . Combination of C-ase treatment could promote the establishment of new axonal connecble for hindlimb locomotion. It has been previously demonstrated that NT3 enhances the sprouting of cortitions to the ipsilateral lumbar motor neurons by supporting axon growth directly through implanted PCL scafcospinal axons and that NT3 signaling plays a critical role in synaptogenesis (25, 42, 55) . The increases in the folds. Alternatively, C-ase treatment might promote the sprouting of contralateral spared axons to the ipsilateral expression of GAP-43 and synaptotagmin indicated that PCL-F3.NT3 implantation markedly promoted neulumbar regions (5, 8) . At any rate, these findings indicated that combination of C-ase treatment compleroplasticity in the caudal spinal cord. Intriguingly, the increase in GAP- 43 
